Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.30 |
| ▸ | HTR2B | P41595 | 2/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28445516 | 0.75 | CYP1A1 (0.32) | CYP1A1CYP1A2 | |
| SCHEMBL28445561 | 0.74 | CYP2A6 (0.41) | HTR2CHTR2BNPSR1 | |
| SCHEMBL28441377 | 0.71 | CYP1A1 (0.32) | CYP1A1CYP1A2 | |
| SCHEMBL93424 | 0.70 | AHR (0.38) | KDM4ECSNK2A1MAPTNPSR1 | |
| SCHEMBL17826761 | 0.65 | L3MBTL1 (0.56) | KDM4ECSNK2A1MAPT | |
| SCHEMBL28443125 | 0.63 | KCNH2 (0.32) | — | |
| SCHEMBL19122260 | 0.63 | KDM4E (0.42) | KDM4ECSNK2A1CYP1A2MAPT | |
| SCHEMBL30629208 | 0.62 | CYP2B6 (0.38) | CYP1A1CYP1A2 | |
| SCHEMBL30623113 | 0.61 | KDM4E (0.42) | KDM4ECYP1A1CYP1A2MAPT | |
| SCHEMBL1477385 | 0.60 | CA1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111417396-A | Methods of treating cancer with small molecule NF-kB inhibitors | 免疫目标公司 | 2020-07-14 | — | — | CN | disclosed |